Skip to main content

Find Clinical Trials

Home
Conditions
Genital Neoplasms, Female

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,599 public trials 1,044 recruiting studies

Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

NCT01065441

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Cancer, +62 more
Locations: Hadassah-Hebrew University Medical Center Jerusalem, Israel

View Trial Details

Completed

Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

NCT03676101

Conditions: AIS, CIN 3, CIN1, +46 more
Locations: Zhejiang Provincial Center for Disease Control and Prevention Hanzhou, China

View Trial Details

Completed

To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors

NCT03159585

Conditions: Adnexal Diseases, Bladder Carcinoma Stage IV, Bone and Soft Tissue Tumors, +49 more
Locations: Zhujiang Hospital of Southern Mediacl University Guangzhou, Guangdong, China

View Trial Details

Completed

Phase Ib Study of Chiauranib in Patients With Ovarian Cancer

NCT03166891

Conditions: Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +17 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

NCT00877877

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations: GSK Investigational Site Bogotá, Colombia

GSK Investigational Site Deggingen, Baden-Wurttemberg, Germany

GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

View all 26 locations

View Trial Details

Completed

Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females

NCT00586339

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +31 more
Locations: GSK Investigational Site Khayelitsha, South Africa

View Trial Details

Completed

Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

NCT00637195

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +30 more
Locations: GSK Investigational Site Ghent, Belgium

GSK Investigational Site La Louvière, Belgium

View Trial Details

Completed

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

NCT00294047

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations: GSK Investigational Site Fountain Valley, California, United States

GSK Investigational Site Aurora, Colorado, United States

GSK Investigational Site Golden, Colorado, United States

GSK Investigational Site Coral Gables, Florida, United States

View all 75 locations

View Trial Details

Completed

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

NCT00423046

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations: GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site San Diego, California, United States

GSK Investigational Site San Francisco, California, United States

GSK Investigational Site Vista, California, United States

View all 40 locations

View Trial Details

Completed

Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in India

NCT03471572

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations: Research Site Bangalore, Karnataka, India

Research Site Mumbai, Maharashtra, India

Research Site Mumbai, Maharashtra, India

Research Site Delhi, New Delhi, India

View Trial Details